Cariprazine’s efficacy in treating depressive symptoms – pooled data from schizophrenia, bipolar depression and major depression trials
Introduction Depressive symptoms are a common feature of schizophrenia (SCH) and define bipolar disorder and major depressive disorder (MDD). Their emergence is related to altered neurotransmission at the serotonin receptors and potentially at dopamine D3 receptors. Objectives The aim of this analy...
Main Authors: | R. S. McIntyre, R. Csehi, G. Németh |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823006648/type/journal_article |
Similar Items
-
Cariprazine’s efficacy in treating affective symptoms – pooled data from schizophrenia and bipolar depression trials
by: R. Mcintyre, et al.
Published: (2022-06-01) -
Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of clinical trial data vs. real-world evidence
by: E. Rancans, et al.
Published: (2023-03-01) -
Benzodiazepine use during cariprazine treatment in acute schizophrenia
by: C. Correll, et al.
Published: (2022-06-01) -
Tolerability and safety profile of cariprazine in treating psychotic disorders, bipolar disorder and major depressive disorder: a systematic review with meta-analysis of randomized controlled trials
by: Lao, K, et al.
Published: (2016) -
Cariprazine add-on for resistant bipolar depression: preliminary results from an italian real-world experience
by: V. Martiadis, et al.
Published: (2023-03-01)